Citadel Advisors’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,000
Closed -$81.5K 14031
2025
Q3
$81.5K Sell
29,000
-30,700
-51% -$87K ﹤0.01% 11962
2025
Q2
$186K Buy
59,700
+29,800
+100% +$82.5K ﹤0.01% 10742
2025
Q1
$61.9K Buy
29,900
+28,700
+2,392% +$42.4K ﹤0.01% 12071
2024
Q4
$2.14K Sell
1,200
-7,800
-87% -$13.7K ﹤0.01% 14115
2024
Q3
$16.6K Sell
9,000
-12,500
-58% -$28.4K ﹤0.01% 12923
2024
Q2
$68.6K Buy
21,500
+600
+3% +$2.27K ﹤0.01% 11398
2024
Q1
$80.5K Sell
20,900
-65,400
-76% -$436K ﹤0.01% 11643
2023
Q4
$557K Sell
86,300
-68,400
-44% -$364K ﹤0.01% 7867
2023
Q3
$724K Buy
154,700
+59,800
+63% +$310K ﹤0.01% 7273
2023
Q2
$694K Buy
94,900
+8,200
+9% +$48.9K ﹤0.01% 7221
2023
Q1
$389K Sell
86,700
-105,000
-55% -$567K ﹤0.01% 8823
2022
Q4
$1.26M Buy
191,700
+92,500
+93% +$558K ﹤0.01% 6369
2022
Q3
$451K Buy
99,200
+76,600
+339% +$391K ﹤0.01% 8696
2022
Q2
$109K Buy
+22,600
New +$95.3K ﹤0.01% 11326

Other funds holding SURG

Citadel Advisors's SURG Position: Q1 2025 in Review

Citadel Advisors sold out of SurgePays (SURG) in Q1 2025, closing a stake of 41,486 shares — an estimated $61.2K sold.

Citadel Advisors first reported a position in SURG in Q4 2021 and held it in 5 quarters. The position peaked at $96.3K in Q2 2023. 29 funds tracked by Wall St. Rank hold SURG as of Q1 2025.

  • Citadel Advisors reported no remaining SurgePays position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 41,486 SurgePays shares in Q1 2025, an estimated $61.2K.
  • Citadel Advisors first reported a position in SurgePays in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's SurgePays position peaked at $96.3K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held SurgePays as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.